Healthcare -
Biotechnology - NASDAQ - US
$ 6.7
-8.34 %
$ 70.1 M
Market Cap
0.07
P/E
AVTX - RESEARCH & DEVELOPMENT
Research & Development AVTX - Avalo Therapeutics, Inc.
13.8 M
LAST VALUE
-52.00%
2 YEAR CAGR
18.96%
5 YEAR CAGR
4.46%
10 YEAR CAGR